245 related articles for article (PubMed ID: 19077543)
1. Block of tetrodotoxin-sensitive, Na(V)1.7 and tetrodotoxin-resistant, Na(V)1.8, Na+ channels by ranolazine.
Rajamani S; Shryock JC; Belardinelli L
Channels (Austin); 2008; 2(6):449-60. PubMed ID: 19077543
[TBL] [Abstract][Full Text] [Related]
2. State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.
Wang GK; Calderon J; Wang SY
Mol Pharmacol; 2008 Mar; 73(3):940-8. PubMed ID: 18079277
[TBL] [Abstract][Full Text] [Related]
3. Block of Na+ currents and suppression of action potentials in embryonic rat dorsal root ganglion neurons by ranolazine.
Hirakawa R; El-Bizri N; Shryock JC; Belardinelli L; Rajamani S
Neuropharmacology; 2012 Jun; 62(7):2251-60. PubMed ID: 22313527
[TBL] [Abstract][Full Text] [Related]
4. Ranolazine block of human Na v 1.4 sodium channels and paramyotonia congenita mutants.
El-Bizri N; Kahlig KM; Shyrock JC; George AL; Belardinelli L; Rajamani S
Channels (Austin); 2011; 5(2):161-72. PubMed ID: 21317558
[TBL] [Abstract][Full Text] [Related]
5. The neuroleptic drug, fluphenazine, blocks neuronal voltage-gated sodium channels.
Zhou X; Dong XW; Priestley T
Brain Res; 2006 Aug; 1106(1):72-81. PubMed ID: 16839522
[TBL] [Abstract][Full Text] [Related]
6. Use-dependent block by lidocaine but not amitriptyline is more pronounced in tetrodotoxin (TTX)-Resistant Nav1.8 than in TTX-sensitive Na+ channels.
Leffler A; Reiprich A; Mohapatra DP; Nau C
J Pharmacol Exp Ther; 2007 Jan; 320(1):354-64. PubMed ID: 17005919
[TBL] [Abstract][Full Text] [Related]
7. Ranolazine selectively blocks persistent current evoked by epilepsy-associated Naν1.1 mutations.
Kahlig KM; Lepist I; Leung K; Rajamani S; George AL
Br J Pharmacol; 2010 Nov; 161(6):1414-26. PubMed ID: 20735403
[TBL] [Abstract][Full Text] [Related]
8. Ranolazine decreases mechanosensitivity of the voltage-gated sodium ion channel Na(v)1.5: a novel mechanism of drug action.
Beyder A; Strege PR; Reyes S; Bernard CE; Terzic A; Makielski J; Ackerman MJ; Farrugia G
Circulation; 2012 Jun; 125(22):2698-706. PubMed ID: 22565935
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
Fredj S; Sampson KJ; Liu H; Kass RS
Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
[TBL] [Abstract][Full Text] [Related]
10. Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels.
Zhou X; Dong XW; Crona J; Maguire M; Priestley T
J Pharmacol Exp Ther; 2003 Aug; 306(2):498-504. PubMed ID: 12730276
[TBL] [Abstract][Full Text] [Related]
11. Use-dependent block of cardiac late Na(+) current by ranolazine.
Rajamani S; El-Bizri N; Shryock JC; Makielski JC; Belardinelli L
Heart Rhythm; 2009 Nov; 6(11):1625-31. PubMed ID: 19879541
[TBL] [Abstract][Full Text] [Related]
12. Voltage- and use-dependent inhibition of Na+ channels in rat sensory neurones by 4030W92, a new antihyperalgesic agent.
Trezise DJ; John VH; Xie XM
Br J Pharmacol; 1998 Jul; 124(5):953-63. PubMed ID: 9692781
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: I. Experimental analysis of the use-dependent block.
Zygmunt AC; Nesterenko VV; Rajamani S; Hu D; Barajas-Martinez H; Belardinelli L; Antzelevitch C
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1606-14. PubMed ID: 21821778
[TBL] [Abstract][Full Text] [Related]
14. Ranolazine reduces neuronal excitability by interacting with inactivated states of brain sodium channels.
Kahlig KM; Hirakawa R; Liu L; George AL; Belardinelli L; Rajamani S
Mol Pharmacol; 2014 Jan; 85(1):162-74. PubMed ID: 24202911
[TBL] [Abstract][Full Text] [Related]
15. Isoflurane inhibits the tetrodotoxin-resistant voltage-gated sodium channel Nav1.8.
Herold KF; Nau C; Ouyang W; Hemmings HC
Anesthesiology; 2009 Sep; 111(3):591-9. PubMed ID: 19672182
[TBL] [Abstract][Full Text] [Related]
16. Irreversible block of cardiac mutant Na+ channels by batrachotoxin.
Wang SY; Tikhonov DB; Mitchell J; Zhorov BS; Wang GK
Channels (Austin); 2007; 1(3):179-88. PubMed ID: 18690024
[TBL] [Abstract][Full Text] [Related]
17. Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability.
Estacion M; Waxman SG; Dib-Hajj SD
Mol Pain; 2010 Jun; 6():35. PubMed ID: 20529343
[TBL] [Abstract][Full Text] [Related]
18. Effects of the antianginal drug, ranolazine, on the brain sodium channel Na(V)1.2 and its modulation by extracellular protons.
Peters CH; Sokolov S; Rajamani S; Ruben PC
Br J Pharmacol; 2013 Jun; 169(3):704-16. PubMed ID: 23472826
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: II. Insights from a mathematical model.
Nesterenko VV; Zygmunt AC; Rajamani S; Belardinelli L; Antzelevitch C
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1615-24. PubMed ID: 21821780
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel voltage-gated Na+ channel rNa(v)1.5a in the rat hippocampal progenitor stem cell line HiB5.
Gersdorff Korsgaard MP; Christophersen P; Ahring PK; Olesen SP
Pflugers Arch; 2001 Oct; 443(1):18-30. PubMed ID: 11692262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
